Illumina, Qiagen Settle DNA Sequencer Patent Dispute
Illumina Inc. has settled patent infringement claims against rival Qiagen NV, according to a California federal judge's order on Friday, resolving a year-old action over DNA-sequencing intellectual property....To view the full article, register now.
Already a subscriber? Click here to view full article